Podocyte injury associated glomerulopathies induced by pamidronate

Kidney International

Volumn 65, Issue 2, 2004, Pages 634-641

  Barri, Yousri M ^a   Munshi, Nikhil C ^b   Sukumalchantra, Suteetat ^b   Abulezz, Sameh R ^b   Bonsib, Stephen M ^b   Wallach, Jeffrey ^b   Walker, Patrick D ^b  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

FSGS; Glomerulonephritis; Multiple Myeloma; Nephrotic syndrome; Pamidronate; Proteinuria

Indexed keywords

PAMIDRONIC ACID;

ADULT; AGED; ARTICLE; CAUCASIAN; CELL DAMAGE; DETERIORATION; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; FEMALE; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY INJURY; LONG TERM CARE; MALE; MULTIPLE MYELOMA; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA;

EID: 1642439058     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00426.x     Document Type: Article

References (27)

1. PASSERI G, ULIETTI V, GIRASOLE G, et al: Bisphosphonates inhibit IL-6 production by human osteoblastic cells. JBMR 9:S230, 1994
2. PLUIJM G, VIOEDGRAVEN H, BEEK E, et al: Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. J Clin Invest 98:698-705, 1996
3. MARKOWITZ GS, APPEL GB, FINE PL, et al: Collapsing focal segmental glomerulosclerosis following treatment with high dose pamidronate. J Am Soc Nephrol 12:1164-1172, 2001
4. DESIKAN R, VEKSLER Y, RAZA S, et al: Nephrotic proteinuria associated with high dose Pamidronate in multiple myeloma. Br J Haematol 119:496-499, 2002
5. WALKER PD, DEEVES EC, SAHBA G, et al: Rapidly progressive glomerulonephritis in a patient with syphilis: Identification of anti-treponemal antibody and treponemal antigen in renal tissue. Am J Med 76:1106-1112, 1984
6. KRANE NK, ESPENAN P, WALKER PD, et al: Renal disease and syphilis: A report of nephrotic syndrome with minimal change disease. Am J Kidney Dis 9:176-179, 1987
7. MARKOWITZ GS, FINE PL, D'AGATI VD: Nephrotic syndrome after treatment with pamidronate. Am J Kidney Dis 39:1118-1122, 2002
8. BOUNAMEAUX HM, SCHIIFFERLI J, MONTANI JP, et al: Renal failure associated with intravenous disphosphanates. Lancer I:471, 1983
9. YATES AJP, GRAY RES, URWIN GH, et al: Intravenous clodronate in the treatment and retreatment of Paget's disease of bone. Lancet I:1474-1477, 1985
10. DUMON JC, MAGRITTE A, BODY JJ: Efficacy and safety of the bisphosphanate tiludronate for the treatment of tumor associated hypocalcaemia. Bone Miner 15:257-266, 1991
11. GREEN JR, SELTENMEYER Y, JAEGGI KA, WIDLER L: Renal tolerability profile of novel, potent bisphosphonates in two short term rat models. Pharmacol Toxicol 80:225-230, 1997
12. FENT K, MAYER E, ZBINDEN G: Nephrotoxicity screening in rats: A validation study. Arch Toxicol 61:349-358, 1988
13. CAL JC, DALEY-YATES PT: Disposition and nephrotoxicity of 3-amino-1-hydroxypropylidene-1, 1-bisphosphonate (APD), in rats and mice. Toxicology 65:179-197, 1990
14. BRAUN JP, RICO AG, BENARD P, et al: Urinary gamma-glutamyl transferase in renal toxicology of the rat. Basis of its use and significance in acute mercurial nephritis. Toxicology 11:73-82, 1978
15. LOCKRIDGE L, PAPAC RJ, PERAZELLA MA: Pamidronate-associated nephrotoxicity in a patient with Langerhan's histiocytosis. Am J Kidney Dis 40:E2, 2002
16. BARISONI L, KRIZ W, MUNDEL P, D'AGATI V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV associated nephropathy. J Am Soc Nephrol 10:51-61, 1999
17. MUNDEL P, SHANKLAND SJ: Podocyte biology and response to injury. J Am Soc Nephrol 13:3005-3015, 2002
18. KERJASCHKI D: Caught flat-footed: Podocyte damage and the molecular basis of focal glomerulosclerosis. J Clin Invest 108:1583-1587, 2001
19. BRENNER BM: Nephron adaptation to renal injury or ablation. Am J Physiol 249:F324-F337, 1985
20. HOSTETTER TH, TROY JL, BRENNER BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410-415, 1981
21. GRISHMAN E, CHURG J, PORUSH JG: Glomerular morphology in nephritic heroin addicts. Lab Invest 35:415-424, 1976
22. BANERJEE D, ASIF A, STRIKER L, et al: Short-term, high dose pamidronate-induced acute tubular necrosis: The postulated mechanisms of bisphosphonate nephrotoxicity. Am J Kidney Dis 41:1-6, 2003
23. LAURINAVICIUS A, HURWITZ S, RENNKE HG: Collapsing glomerulopathy in HIV and non-HIV patients: A clinicopathological and follow-up study. Kidney Int 56:2203-2213, 1999
24. VAN BUUREN AJ, BATES WD, MULLER N: Nephrotic syndrome in Namibian children. S Afr Med J 89:1088-1091, 1999
25. GOPALANI A, AHUJA TS: Prevalence of glomerulopathies in autopsies of patients infected with the hepatitis C virus. Am J Med Sci 322:57-60, 2001
26. TANAWATTANACHAROEN S, FALK RJ, JENNETTE JC, KOPP JB: Parvovirus B19 in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis 35:166-1174, 2000
27. MOUDGIL A, NAST CC, BAGGA A, et al: Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 59:2126-2133, 2001